The problem of model indistinguishability in pharmacokinetics
- PMID: 2677314
- DOI: 10.1007/BF01059030
The problem of model indistinguishability in pharmacokinetics
Abstract
The problem of model indistinguishability is introduced in the context of linear compartmental models in pharmacokinetics. The two most widely used methods of analyzing model indistinguishability are described. It is shown that as the number of compartments increases, one approach, based on the Laplace transforms of the observations, although conceptually simple, can result in very large numbers of candidate models to be examined for indistinguishability, while the other approach, based on similarity transformations, although systematic, often results in very difficult algebraic expressions. These problems can be eased by the use of some simple geometrical rules, used at the outset of an indistinguishability analysis. The approach is illustrated by application of two 2-compartment drug, 2-compartment metabolite models.
Similar articles
-
Identifiability and indistinguishability of nonlinear pharmacokinetic models.J Pharmacokinet Biopharm. 1994 Jun;22(3):229-51. doi: 10.1007/BF02353330. J Pharmacokinet Biopharm. 1994. PMID: 7884651 Review.
-
Structural identifiability and indistinguishability of compartmental models.Expert Opin Drug Metab Toxicol. 2009 Mar;5(3):295-302. doi: 10.1517/17425250902773426. Expert Opin Drug Metab Toxicol. 2009. PMID: 19331592 Review.
-
Indistinguishability for a class of nonlinear compartmental models.Math Biosci. 1994 Jan;119(1):77-95. doi: 10.1016/0025-5564(94)90005-1. Math Biosci. 1994. PMID: 8111137
-
Structural identifiability and indistinguishability of certain two-compartment models incorporating nonlinear efflux from the peripheral compartment.Math Biosci. 1995 Jan;125(1):61-81. doi: 10.1016/0025-5564(94)00023-s. Math Biosci. 1995. PMID: 7881189
-
Indistinguishability and identifiability analysis of linear compartmental models.Math Biosci. 1991 Feb;103(1):77-95. doi: 10.1016/0025-5564(91)90092-w. Math Biosci. 1991. PMID: 1804443
Cited by
-
Statistical considerations in pharmacokinetic study design.Clin Pharmacokinet. 1993 May;24(5):380-7. doi: 10.2165/00003088-199324050-00003. Clin Pharmacokinet. 1993. PMID: 8504622 Review.
-
Identifiability and indistinguishability of nonlinear pharmacokinetic models.J Pharmacokinet Biopharm. 1994 Jun;22(3):229-51. doi: 10.1007/BF02353330. J Pharmacokinet Biopharm. 1994. PMID: 7884651 Review.
-
Bootstrapping for pharmacokinetic models: visualization of predictive and parameter uncertainty.Pharm Res. 1998 May;15(5):690-7. doi: 10.1023/a:1011958717142. Pharm Res. 1998. PMID: 9619776
-
An experimental design strategy for quantitating complex pharmacokinetic models: enterohepatic circulation with time-varying gallbladder emptying as an example.Pharm Res. 1992 Feb;9(2):169-77. doi: 10.1023/a:1018968819366. Pharm Res. 1992. PMID: 1553336
-
Guiding dose selection of monoclonal antibodies using a new parameter (AFTIR) for characterizing ligand binding systems.J Pharmacokinet Pharmacodyn. 2019 Jun;46(3):287-304. doi: 10.1007/s10928-019-09638-3. Epub 2019 Apr 29. J Pharmacokinet Pharmacodyn. 2019. PMID: 31037615